Showing results (951-960 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|January 2, 2026
Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocolHyo Jung Park, Jonggi Choi, Dong Wook Kim, et al.
Hepatology Communications|May 5, 2020
Drug-Induced Liver Injury in GI PracticeNaemat Sandhu, Victor Navarro
Hepatology Communications|May 5, 2020
Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder PerspectiveJ Konadu Fokuo, Carmen L Masson, August Anderson, et al.
Hepatology Communications|May 5, 2020
Validation of PAS Kinase, a Regulator of Hepatic Fatty Acid and Triglyceride Synthesis, as a Therapeutic Target for Nonalcoholic SteatohepatitisWojciech Swiatek, K Mark Parnell, G Allen Nickols, et al.
Hepatology Communications|May 5, 2020
Integrated GWAS and mRNA Microarray Analysis Identified IFNG and CD40L as the Central Upstream Regulators in Primary Biliary CholangitisKazuko Ueno, Yoshihiro Aiba, Yuki Hitomi, et al.
Hepatology Communications|May 5, 2020
Interindividual Diversity in Expression of Organic Anion Uptake Transporters in Normal and Cirrhotic Human LiverTatsuya Taniguchi, Alana Zanetti-Yabur, Pijun Wang, et al.
Hepatology Communications|May 5, 2020
Lipoprotein-Like Nanoparticle Carrying Small Interfering RNA Against Spalt-Like Transcription Factor 4 Effectively Targets Hepatocellular Carcinoma Cells and Decreases Tumor BurdenWilliam Cruz, Huang Huang, Brian Barber, et al.
Hepatology Communications|September 17, 2021
TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular DiseaseFei Luo, Federico Oldoni, Avash Das
Hepatology Communications|August 29, 2025
Carbon-ion radiotherapy achieves outcomes equivalent to surgical resection for hepatocellular carcinomaTakeshi Hatanaka, Kei Shibuya, Satoru Kakizaki, et al.
Hepatology Communications|August 29, 2025
Pathological study of the tumor microenvironment after neoadjuvant therapy in hepatocellular carcinoma: Difference of TACE combined with antiangiogenics and immunotherapyXintao He, Yanhong Liu, Tianyi Dai, et al.
Pageof 179